2006-002649-35: A Phase IV, Single-Centre, Observer-Blind, Controlled, Randomized Study to Compare the Safety and Immunogenicity of Fluvirin® to Influvac® Administered to Healthy Children 3 to 12 Years of Age. |
|
|
| Ongoing | 4 | 200 | Europe | FLUVIRIN® Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur., Agrippal®, FLUVIRIN®, FLUVIRIN® Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur., Agrippal®, FLUVIRIN® Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur., Agrippal® | Novartis Vaccines and Diagnostics S.r.l. | Prophylaxis of influenza | | | | |
